StockNews.com Initiates Coverage on Aeterna Zentaris (NASDAQ:AEZS)
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report released on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 price objective on shares of Aeterna Zentaris in a research note on Thursday, […]